Yale 2020 Quotes

If we analyze white supremacy from the philosophical lens of Star Wars, then it is all the Sith Lords, the Empire, and the First Order commanded by the Dark Side of the Force. It wants to dominate and impose its will on all galaxies, even those far, far away. Let’s just call this insidious force THE WHITENESS. The Whiteness’s ability to inspire fear and anger is so strong that it corrupted many well-​intentioned people, including people of color, to vote for an incompetent vulgarian in 2016 and 2020. It deludes many liberal and “moderate” whites into believing that they are the “good” ones who are committed to social justice as they talk about white privilege but never actually give up any of it. Still, they’ll have these discussions about racial equality with their white friends in establishments with white patrons from white neighborhoods—​without including the rest of us. The Whiteness has always played for all the marbles. It’s not interested in diplomacy, a representative government, free and fair elections, equitable pay, and a delicious buffet of meals from a multitude of countries. It needs a border wall, a Muslim Ban, and affirmative action for wealthy white students at Yale University. It’s a system, a structure, a paradigm, an ideology whose ultimate goal is domination and submission by any means necessary.

In April, Dr. Vladimir (Zev) Zelenko, M.D., an upstate New York physician and early HCQ adopter, reproduced Dr. Didier Raoult’s “startling successes” by dramatically reducing expected mortalities among 800 patients Zelenko treated with the HCQ cocktail.29 By late April of 2020, US doctors were widely prescribing HCQ to patients and family members, reporting outstanding results, and taking it themselves prophylactically. In May 2020, Dr. Harvey Risch, M.D., Ph.D. published the most comprehensive study, to date, on HCQ’s efficacy against COVID. Risch is Yale University’s super-eminent Professor of Epidemiology, an illustrious world authority on the analysis of aggregate clinical data. Dr. Risch concluded that evidence is unequivocal for early and safe use of the HCQ cocktail. Dr. Risch published his work—a meta-analysis reviewing five outpatient studies—in affiliation with the Johns Hopkins Bloomberg School of Public Health in the American Journal of Epidemiology, under the urgent title, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to Pandemic Crisis.”30 He further demonstrated, with specificity, how HCQ’s critics—largely funded by Bill Gates and Dr. Tony Fauci31—had misinterpreted, misstated, and misreported negative results by employing faulty protocols, most of which showed HCQ efficacy administered without zinc and Zithromax which were known to be helpful. But their main trick for ensuring the protocols failed was to wait until late in the disease process before administering HCQ—when it is known to be ineffective. Dr. Risch noted that evidence against HCQ used late in the course of the disease is irrelevant. While acknowledging that Dr. Didier Raoult’s powerful French studies favoring HCQ efficacy were not randomized, Risch argued that the results were, nevertheless, so stunning as to far outweigh that deficit: “The first study of HCQ + AZ [ . . . ] showed a 50-fold benefit of HCQ + AZ vs. standard of care . . . This is such an enormous difference that it cannot be ignored despite lack of randomization.”32 Risch has pointed out that the supposed need for randomized placebo-controlled trials is a shibboleth. In 2014 the Cochrane Collaboration proved in a landmark meta-analysis of 10,000 studies, that observational studies of the kind produced by Didier Raoult are equal

Many legacy institutions (like Kodak) once were able to make a great living resting on their laurels. According to Yale professor Richard Foster, in the 1920s the average life span of an S&P 500 company was sixty-seven years.14 Not anymore. Today the final three Ds in our chain reaction can disassemble companies and disrupt industries almost overnight, reducing the average life span of a twenty-first-century S&P 500 company to only fifteen years. Ten years from now, according to research done at the Babson School of Business, more than 40 percent of today’s top companies will no longer exist.15 “By 2020,” comments Foster, “more than three quarters of the S&P 500 will be companies that we have not heard of yet.

According to Yale professor Richard Foster, in the 1920s the average life span of an S&P 500 company was sixty-seven years.14 Not anymore. Today the final three Ds in our chain reaction can disassemble companies and disrupt industries almost overnight, reducing the average life span of a twenty-first-century S&P 500 company to only fifteen years. Ten years from now, according to research done at the Babson School of Business, more than 40 percent of today’s top companies will no longer exist.15 “By 2020,” comments Foster, “more than three quarters of the S&P 500 will be companies that we have not heard of yet.